Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.32 USD | +0.76% | -8.33% | +94.12% |
Apr. 18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
Apr. 18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
Business Summary
Number of employees: 33
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 10-07-05 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | Dec. 10 |
Khursheed Anwer
CTO | Chief Tech/Sci/R&D Officer | 64 | 14-06-19 |
Kimberly Bragg
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-07 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 11-07-07 |
James Dentzer
BRD | Director/Board Member | 57 | 22-10-02 |
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Donald Braun
BRD | Director/Board Member | 74 | 15-12-14 |
Stacy Lindborg
BRD | Director/Board Member | 53 | 21-06-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,399,811 | 9,291,441 ( 98.85 %) | 22 ( 0.000234 %) | 98.85 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+92.65% | 12.31M | |
-1.65% | 103B | |
+6.75% | 101B | |
+6.84% | 23.07B | |
-12.60% | 22.23B | |
-5.01% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- IMNN Stock
- Company Imunon, Inc.